We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: 16 investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
The British Snack Co makes quirky and original British snacks. The company's award-winning flavours and unique ranges of craft popcorn, crisps, and pork snacks have sold over 8 million bags to date. It aims to be a contender in the £3.2 billion UK snacks market. The company's products are stocked across major retailers like Waitrose, Ocado's, Morrisons, Borough Box, and Amazon, to name a few. Its craft pork scratching product, Awfully Posh, was the first pork snack ever to win a Great Taste Award. The company has been working with buyers in the hospitality industry to create joint marketing plans for after lockdown to rapidly grow its Out Of Home (OOH) sales. It will use 50% of the investment to grow its staff, 37.5% towards trade marketing, and 12.5% for New Product Development (NPD).
days to go: Expired investment: £382,495
GIBIE combines ancient Indian dying methods with modern weaving technologies to produce sustainable and luxurious homewares. The company argues that the textile industry uses an astonishing 9 trillion gallons of water annually, as well as, releases harmful gases and chemicals in the air and water. GIBIE aims to change this scenario by bringing forth sustainable linen that has superior qualities to chemically enhanced and dyed linen. It has come out with an industrial-scale production proposal of its linen. The company is a PETA-approved vegan brand and a member of the Color Ashram Foundation that promotes the usage of herbal dyes around the world. GIBIE will use the investment to launch its essential sales programs, boost marketing initiatives and scale production.

Pitch Rated

57%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £158,571
The Baby Room is an independent luxury online retailer of furniture, nursery goods, designer clothing and footwear for babies and children. The company has 12,000 e-mail subscribers, 4,300 Facebook Likes, £260 Average Basket Value, and 26% repeat customers. Moreover, the company has tier 1 relationships with Versace, Fendi, Moschino, and Silver Cross. The Baby Room has achieved a new 1st-year turnover of £4.7M and £101K net profit, achieving a 15 fold increase in turnover (2018-19). With the proceeds, the company will enhance its infrastructure and team.
days to go: Expired investment: £22,080
Wild & Stone (W&S) is on a mission to make sustainable and stylish items the natural alternatives to commonly used plastics with products like bamboo toothbrushes and reusable steel razors. W&S stresses that its products carry a 30-day no-quibble returns policy, and for every order, it donates to the Marine Conservation Society. W&S argues that it has completed over 100,000 orders, grown its range to include over 85 products, and earned over £850,000 in revenue since its launch. It also points out that it is listed on major marketplaces including, Amazon, NOTHS, Wayfair, eBay, and Etsy. W&S products have been nominated for multiple Amazon choice awards. Its founder, Kathryn Jonas, was shortlisted for the 'Sustainability Entrepreneur of the Year, Southeast region' at the Great British Entrepreneur Awards 2021. The company has featured in publications such as Vogue, The Times, Tatler, Elle, and The Independent. They state they will use the investment to increase its product range and level of inventory.
days to go: Expired investment: £250,460
Feed is a platform that automates digital advertising for musicians and creators by enabling them to grow an audience and build their businesses. The creator needs to connect their social media accounts to the Feed portal and set a budget. The portal will then create ads that reach new people and convert engaged audiences into loyal fans over time. The company asserts that existing ad generation platforms are too complex, time-consuming and expensive for creators. Feed argues that its portal caters to a variety of budgets, requires no marketing knowledge and takes minutes to get started. The beta platform is integrated with Facebook's & Instagram's ad network and has 500 creators on board. The company will use the investment to launch the paid version of Feed in Q4 2020. 

Pitch Rated

47%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £146,117
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph